PharmaSGP Holding SE (PSG) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.115x

Based on the latest financial reports, PharmaSGP Holding SE (PSG) has a cash flow conversion efficiency ratio of 0.115x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.22 Million ≈ $4.94 Million USD) by net assets (€36.67 Million ≈ $42.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

PharmaSGP Holding SE - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how PharmaSGP Holding SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PSG total liabilities for a breakdown of total debt and financial obligations.

PharmaSGP Holding SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PharmaSGP Holding SE ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tatva Chintan Pharma Chem Limited NSE:TATVA	0.017x
Test Rite International Co Ltd TW:2908	0.118x
Danal Co. Ltd KQ:064260	-0.042x
GEOPARK LTD. DL -001 F:G6O	N/A
Fusion Micro Finance Limited NSE:FUSION	0.232x
Suzhou Shijing Environmental Technology Co.Ltd. SHE:301030	N/A
EUROSEAS LTD DL -01 F:2LE1	N/A
Kits Eyecare Ltd TO:KITS	0.048x

Annual Cash Flow Conversion Efficiency for PharmaSGP Holding SE (2014–2024)

The table below shows the annual cash flow conversion efficiency of PharmaSGP Holding SE from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see PSG company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€31.96 Million ≈ $37.37 Million	€24.88 Million ≈ $29.08 Million	0.778x	+16.15%
2023-12-31	€39.75 Million ≈ $46.48 Million	€26.64 Million ≈ $31.14 Million	0.670x	-15.68%
2022-12-31	€31.10 Million ≈ $36.36 Million	€24.71 Million ≈ $28.89 Million	0.795x	+44.12%
2021-12-31	€22.20 Million ≈ $25.95 Million	€12.24 Million ≈ $14.31 Million	0.551x	-58.95%
2020-12-31	€11.51 Million ≈ $13.45 Million	€15.46 Million ≈ $18.07 Million	1.343x	+628.25%
2019-12-31	€95.58 Million ≈ $111.74 Million	€17.63 Million ≈ $20.61 Million	0.184x	-20.63%
2017-12-31	€61.32 Million ≈ $71.68 Million	€14.25 Million ≈ $16.66 Million	0.232x	+276.99%
2016-12-31	€57.53 Million ≈ $67.26 Million	€3.55 Million ≈ $4.15 Million	0.062x	-68.67%
2015-12-31	€53.79 Million ≈ $62.88 Million	€10.59 Million ≈ $12.38 Million	0.197x	+75.71%
2014-12-31	€48.27 Million ≈ $56.43 Million	€5.41 Million ≈ $6.32 Million	0.112x	--

About PharmaSGP Holding SE

F:PSG Germany

Market Cap

$387.63 Million

€331.56 Million EUR

Market Cap Rank

#14548 Global

#1434 in Germany

Share Price

€28.80

Change (1 day)

+0.70%

52-Week Range

€23.40 - €29.60

All Time High

€32.32